Sherwin-Williams (NYSE:SHW) PT Raised to $412.00 at UBS Group

Sherwin-Williams (NYSE:SHW) had its price target hoisted by investment analysts at UBS Group from $375.00 to $412.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the specialty chemicals company’s stock. UBS Group’s target price would indicate a potential upside of 11.54% from the stock’s current price.

A number of other equities research analysts have also issued reports on SHW. KeyCorp increased their price target on Sherwin-Williams from $400.00 to $410.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 24th. Jefferies Financial Group raised their price objective on Sherwin-Williams from $392.00 to $415.00 and gave the company a “buy” rating in a research report on Monday, August 26th. Wells Fargo & Company lifted their price target on Sherwin-Williams from $320.00 to $350.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 24th. Barclays raised their price objective on shares of Sherwin-Williams from $315.00 to $355.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 24th. Finally, Evercore ISI raised their price objective on shares of Sherwin-Williams from $365.00 to $380.00 and gave the stock an “outperform” rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $361.95.

Sherwin-Williams Stock Performance

Sherwin-Williams stock opened at $369.37 on Friday. The company has a quick ratio of 0.50, a current ratio of 0.81 and a debt-to-equity ratio of 2.17. The company has a market capitalization of $93.65 billion, a P/E ratio of 39.38, a PEG ratio of 2.79 and a beta of 1.16. The stock’s 50 day moving average is $332.64 and its 200 day moving average is $323.02. Sherwin-Williams has a twelve month low of $232.06 and a twelve month high of $370.27.

Sherwin-Williams (NYSE:SHW) last issued its earnings results on Tuesday, July 23rd. The specialty chemicals company reported $3.70 EPS for the quarter, beating the consensus estimate of $3.51 by $0.19. The business had revenue of $6.27 billion for the quarter, compared to the consensus estimate of $6.33 billion. Sherwin-Williams had a return on equity of 75.58% and a net margin of 10.92%. The company’s revenue was up .5% compared to the same quarter last year. During the same period last year, the business posted $3.29 EPS. On average, equities research analysts predict that Sherwin-Williams will post 11.44 earnings per share for the current fiscal year.

Institutional Trading of Sherwin-Williams

Several hedge funds and other institutional investors have recently made changes to their positions in SHW. HHM Wealth Advisors LLC boosted its holdings in shares of Sherwin-Williams by 102.3% in the second quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. First United Bank & Trust acquired a new stake in shares of Sherwin-Williams in the fourth quarter valued at about $31,000. Semmax Financial Advisors Inc. lifted its stake in shares of Sherwin-Williams by 136.4% in the second quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 60 shares during the period. Tortoise Investment Management LLC lifted its stake in shares of Sherwin-Williams by 158.5% in the fourth quarter. Tortoise Investment Management LLC now owns 106 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 65 shares during the period. Finally, VitalStone Financial LLC lifted its stake in shares of Sherwin-Williams by 233.3% in the second quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 77 shares during the period. Hedge funds and other institutional investors own 77.67% of the company’s stock.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.